DDX17 and hepatocellular carcinoma: These findings align with those of previous studies, which have shown that DDX17 regulates alternative splicing, leading to the production of an oncogenic isoform of PXN-AS1 and promoting hepatocellular carcinoma (HCC) metastasis.